as on September 16, 2025 at 1:29 am IST
Day's Low
Day's High
3.10%
Downside
4.14%
Upside
52 Week's Low
52 Week's High
58.62%
Downside
493.10%
Upside
Check Evaxion Biotech A/s market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$18.6M
EPS (TTM)
-0.04
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-13.6M
Revenue (TTM)
3.2M
Profit Margin
0.00%
Return On Equity TTM
6054100.00%
Compare market cap, revenue, PE, and other key metrics of Evaxion Biotech A/s with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $18.6M | NA | NA | 0.00% | |
BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
BUY | $59.4B | -3.43% | 14.11 | 31.37% |
The Evaxion Biotech A/s stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Evaxion Biotech A/s investment value today
Current value as on today
₹24,319
Returns
Returns from Evaxion Biotech A/s Stock
Dollar Returns*
₹4,985 (+4.99%)
Based on 9 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Evaxion Biotech A/s. Average target price of $13.25
Get share price movements and forecasts by analysts on Evaxion Biotech A/s.
What analysts predicted
78.11%UPSIDE
Target Price
$13.25
Current Price
$2.9
Analyzed by
9 Analysts
Target
$13.25
Evaxion Biotech A/s target price $13.25, a slight upside of 78.11% compared to current price of $2.9. According to 9 analysts rating.
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 156.0%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 220.6%
Price Dip
In the last 1 year, EVAX stock has moved down by -80.4%
Organisation | Evaxion Biotech A/s |
Headquarters | Dr. Neergaards Vej, Horsholm, Denmark, 2970 |
CEO | Dr. Birgitte Rono Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Andreas Holm Mattsson | Founder & Chief AI Officer |
Mr. Thomas Frederik Schmidt M.Sc. | Chief Financial Officer |
Dr. Birgitte Rono Ph.D. | Interim CEO & Chief Scientific Officer |
Evaxion Biotech A/s share price today is $2.9 as on at the close of the market. Evaxion Biotech A/s share today touched a day high of $3.02 and a low of $2.81.
Evaxion Biotech A/s share touched a 52 week high of $17.2 on and a 52 week low of $1.2 on . Evaxion Biotech A/s stock price today i.e. is closed at $2.9,which is 83.14% down from its 52 week high and 141.67% up from its 52 week low.
Evaxion Biotech A/s market capitalisation is $0.00T as on .
Indian investors can start investing in Evaxion Biotech A/s (EVAX) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Evaxion Biotech A/s stock (as per the Rupee-Dollar exchange rate as on ).
Based on Evaxion Biotech A/s share’s latest price of $2.9 as on September 16, 2025 at 1:29 am IST, you will get 3.4483 shares of Evaxion Biotech A/s. Learn more about
fractional shares .